LabCorp’s newly-launched test offering to have future applications in clinical research

By Melissa Fassbender contact

- Last updated on GMT

Pixel by LabCorp (Image: Business Wire)
Pixel by LabCorp (Image: Business Wire)

Related tags: LabCorp, Covance, Testing

LabCorp has launched Pixel by LabCorp, a consumer-initiated wellness test offering that allows for sample self-collection and access to online results.

During the company’s most recent earnings call​, LabCorp CEO David King said the company was preparing to launch the wellness testing offering. As he explained at the time, the offering will be expanded and will have application in its drug development business, Covance.

The offering falls in line with the company’s aim to support trials with “convenient, accurate testing outside the physician office,”​ King said.

“The ability to make testing more accessible and convenient can help support clinical research in a variety of ways, from initial eligibility screening to remote patient monitoring,”​ Donald Von Hagen, LabCorp, vice president, corporate communications, told us.

“We plan to pursue these types of opportunities in the future as we continue to develop Pixel by LabCorp,”​ he said.

The test packages can be purchased at and include a physician review and order, which are required for all Pixel by LabCorp testing, the company explained. Most testing requires a few drops of blood collected from the fingertip.

The offering will initially provide screens for wellness, heart health, diabetes, and colorectal cancer.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more